Five integrated service lines designed to address the full commercialization journey — from regulatory strategy through market entry and revenue growth.
Precision Roadmaps for Global Healthcare Markets
MedTech companies entering new geographies frequently underestimate the complexity of healthcare market dynamics — from fragmented payer landscapes and hospital procurement hierarchies to regulatory reciprocity gaps and distributor alignment challenges. The result is delayed revenue, misallocated resources, and missed market windows.
We conduct rigorous market sizing, competitive positioning, and stakeholder mapping to build entry strategies grounded in operational reality. Our analysis spans market segmentation, pricing architecture, channel strategy, and KOL engagement planning — tailored to each target geography's unique healthcare infrastructure.
Navigating FDA, EU MDR, and Global Frameworks with Confidence
Regulatory missteps are among the most costly and time-consuming setbacks in MedTech commercialization. Misclassified devices, inadequate clinical evidence packages, and poorly structured submissions can delay market entry by 12–24 months and consume disproportionate capital — particularly for AI-based medical devices where regulatory frameworks are still evolving.
We provide strategic regulatory counsel that begins at product design and continues through post-market surveillance. Our approach integrates device classification strategy, predicate analysis, clinical evidence planning, and submission preparation — with direct experience across FDA 510(k), De Novo, PMA, EU MDR, and IMDRF frameworks.
Translating Algorithms into Clinical and Commercial Value
Healthcare AI companies frequently excel at model development but struggle with the commercial translation — defining clinical use cases that drive adoption, building the evidence base that satisfies clinical buyers, navigating reimbursement pathways, and structuring business models that align with hospital economics.
We work with AI healthcare companies to define their clinical value proposition, build the evidence architecture required for institutional adoption, and design commercial models that reflect how health systems actually make purchasing decisions. Our engagements span diagnostic AI, clinical decision support, remote monitoring platforms, and AI-enabled medical devices.
Building Durable Relationships with Health Systems
Hospital partnerships are among the most valuable and most mismanaged assets in MedTech commercialization. Companies frequently approach health systems with product-centric pitches rather than system-aligned value propositions — resulting in long sales cycles, pilot fatigue, and partnerships that never scale.
We help MedTech companies design and execute hospital engagement strategies that align with health system priorities — quality improvement, cost reduction, and patient outcomes. Our work includes stakeholder mapping, value proposition development, pilot program design, and partnership agreement structuring.
From Strategy to Revenue — With Operational Precision
Strategic plans without execution infrastructure rarely generate revenue. MedTech companies — particularly those at the seed-to-Series B stage — often lack the commercial infrastructure, talent frameworks, and operational systems required to translate market entry strategies into consistent revenue growth.
We support GTM execution through commercial infrastructure design, sales process development, pricing and contracting strategy, and revenue operations setup. Our engagements are structured to build internal capability, not dependency — equipping your team with the frameworks, tools, and processes to execute independently.